Compare Free Cash Flow Operating Cash Flow Ratio Across Equities
You can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible positions. Check out your portfolio center.
Cross Equities Free Cash Flow Operating Cash Flow Ratio Analysis
Compare Terns Pharmaceuticals, PDS Biotechnology Corp, and Inozyme Pharma Free Cash Flow Operating Cash Flow Ratio Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TERN | 1.0135 | 1.0135 | 1.0135 | 1.0135 | 1.0135 | 1.0135 | 1.0135 | 1.0135 | 1.0135 | 1.0136 | 1.0196 | 1.0081 | 1.0056 | 1.0008 | 1.11 |
PDSB | 1.0003 | 1.0003 | 1.0003 | 1.017 | 1.0911 | 1.06 | 1.0213 | 1.0046 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.15 | 1.13 |
INZY | 1.0274 | 1.0274 | 1.0274 | 1.0274 | 1.0274 | 1.0274 | 1.0274 | 1.0274 | 1.0274 | 1.0074 | 1.0158 | 1.0082 | 1.0071 | 1.0042 | 1.11 |
HOOK | 1.1089 | 1.1089 | 1.1089 | 1.1089 | 1.1089 | 1.1089 | 1.1089 | 1.1089 | 1.1434 | 1.0479 | 1.0603 | 1.1906 | 1.2509 | 1.0723 | 0.9 |
DAWN | 1.0068 | 1.0068 | 1.0068 | 1.0068 | 1.0068 | 1.0068 | 1.0068 | 1.0068 | 1.0068 | 1.0068 | 1.0068 | 1.1648 | 1.0002 | 1.022 | 1.16 |
XFOR | 1.0157 | 1.0157 | 1.0157 | 1.0157 | 1.0157 | 1.0157 | 1.0034 | 1.0015 | 1.0008 | 1.0036 | 1.0232 | 1.0087 | 1.0013 | 1.0006 | 1.11 |
ABOS | 1.0022 | 1.0022 | 1.0022 | 1.0022 | 1.0022 | 1.0022 | 1.0022 | 1.0022 | 1.0022 | 1.0022 | 1.0022 | 1.0022 | 1.0046 | 1.0005 | 1.1 |
ELEV | 1.0058 | 1.0058 | 1.0058 | 1.0058 | 1.0058 | 1.0058 | 1.0058 | 1.0058 | 1.0058 | 1.0058 | 1.0058 | 1.001 | 1.001 | 1.15 | 1.1 |
HEPA | 1.0116 | 1.0116 | 1.0116 | 1.0116 | 1.0086 | 1.0004 | 1.0008 | 1.0 | 1.0068 | 1.0068 | 1.0054 | 1.0042 | 1.0005 | 1.0003 | 1.1 |
Terns Pharmaceuticals, PDS Biotechnology Corp, and Inozyme Pharma Free Cash Flow Operating Cash Flow Ratio description
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Baby Boomer Prospects Invested over 40 shares | ||
Hedge Favorites Invested over 50 shares | ||
Automobiles and Trucks Invested over 200 shares | ||
Dividend Beast Invested over 50 shares | ||
Warren Buffett Holdings Invested few shares | ||
Investor Favorites Invested over 40 shares | ||
Blockchain Invested few shares | ||
Impulse Invested few shares | ||
Macroaxis Index Invested few shares | ||
Investing Invested few shares | ||
Technology Invested few shares | ||
Millennials Best Invested few shares | ||
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |